Item 8.01 Other Information.

On February 17, 2021, SiTime Corporation (the "Company") and MegaChips Corporation (the "Selling Stockholder") entered into an Underwriting Agreement (the "Underwriting Agreement") with Barclays Capital Inc., Credit Suisse Securities (USA) LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several underwriters named on Schedule I thereto (the "Underwriters"), relating to the offering and sale (the "Offering") of 3,000,000 shares of the Company's common stock, par value $0.0001 per share. Of these shares, 1,500,000 shares were offered by the Selling Stockholder, and 1,500,000 shares were offered by the Company. The price to the public in the Offering is $127.00 per share of common stock. Pursuant to the Underwriting Agreement, the Underwriters have a 30-day option to purchase up to an additional 450,000 shares of common stock from the Company on the same terms and conditions. The Offering is scheduled to close on February 22, 2021, subject to the satisfaction of customary closing conditions. The shares of common stock are listed on The Nasdaq Global Select Market.

The Offering is being made pursuant to the Company's effective shelf registration statement on Form S-3 (Registration No. 333-253139) filed with the Securities and Exchange Commission (the "SEC") on February 16, 2021, which was automatically effective upon filing. The Company filed with the SEC a preliminary prospectus supplement, dated February 16, 2021, and a final prospectus supplement, dated February 18, 2021, relating to the offer and sale of the shares.

Barclays Capital Inc., Credit Suisse Securities (USA) LLC and Stifel, Nicolaus & Company, Incorporated are acting as joint book-running managers. Needham & Company, LLC, Raymond James & Associates, Inc. and Roth Capital Partners, LLC are acting as co-managers.

The Underwriting Agreement contains customary representations, warranties and agreements by the Company and the Selling Stockholder, customary conditions to closing, indemnification obligations of the Company, the Selling Stockholder and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, and were solely for the benefit of the parties to such agreement.

The Underwriting Agreement is filed as Exhibit 1.1 hereto. The foregoing description of the terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit. A copy of the opinion of Cooley LLP relating to the shares in the Offering is attached as Exhibit 5.1 hereto.

--------------------------------------------------------------------------------

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit No.       Description

 1.1                Underwriting Agreement, dated February  17, 2021, by and among
                  the Company, MegaChips Corporation, as the selling stockholder,
                  Barclays Capital Inc., Credit Suisse Securities (USA) LLC and
                  Stifel, Nicolaus  & Company, Incorporated, as representatives of
                  the several underwriters named on Schedule I thereto.

 5.1                Opinion of Cooley LLP

23.1                Consent of Cooley LLP (contained in Exhibit 5.1)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses